EVFM•benzinga•
Evofem Partners With Windtree Therapeutics to Slash PHEXXI Manufacturing Costs By 55%-60% Through New License And Supply Agreement; There Will Be No Cost To Evofem For The Tech Transfer To The New Manufacturer Engaged By Windtree.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 26, 2025 by benzinga